Long struggle for appropriately processed manufacturer data leads to a new assessment of memantine
Wednesday, April 27, 2011 - 10:00
in Health & Medicine
After the manufacturer of the Alzheimer's drug memantine submitted a supplementary analysis of study data, the German Institute for Quality and Efficiency in Health Care (IQWiG) sees proof of a benefit of the drug for cognitive function, as well as ...
